Covid-19: Novavax vaccine efficacy is 86% against UK variant and 60% against South African variant
- PMID: 33526412
- DOI: 10.1136/bmj.n296
Covid-19: Novavax vaccine efficacy is 86% against UK variant and 60% against South African variant
LinkOut - more resources
Full Text Sources
Other Literature Sources